NCT02762929View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

430

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
Postoperative PainBunions
Interventions
DRUG

HTX-011A

HTX-011A (bupivacaine/meloxicam), via injection.

BIOLOGICAL

Saline Placebo

Saline placebo via injection.

DRUG

HTX-011B

HTX-011B (bupivacaine/meloxicam), via injection or instillation.

DRUG

HTX-002

HTX-002, via injection.

DRUG

Bupivacaine HCl

Bupivacaine HCI, via injection.

DRUG

HTX-009

HTX-009, via injection.

Trial Locations (5)

21122

Pasadena

77027

Houston

78229

San Antonio

92801

Anaheim

93311

Bakersfield

Sponsors

Lead Sponsor

Heron Therapeutics
All Listed Sponsors
lead

Heron Therapeutics

INDUSTRY